APA (7th ed.) Citation

S, C., JA, J., SR, P., WM, B., ML, S., M, M., . . . SR, S. (2025). Complement is activated in patients with acute chest syndrome caused by sickle cell disease and represents a therapeutic target. Science translational medicine, 17(807), eadl4922. https://doi.org/10.1126/scitranslmed.adl4922

Chicago Style (17th ed.) Citation

S, Chonat, et al. "Complement Is Activated in Patients with Acute Chest Syndrome Caused by Sickle Cell Disease and Represents a Therapeutic Target." Science Translational Medicine 17, no. 807 (2025): eadl4922. https://doi.org/10.1126/scitranslmed.adl4922.

MLA (9th ed.) Citation

S, Chonat, et al. "Complement Is Activated in Patients with Acute Chest Syndrome Caused by Sickle Cell Disease and Represents a Therapeutic Target." Science Translational Medicine, vol. 17, no. 807, 2025, p. eadl4922, https://doi.org/10.1126/scitranslmed.adl4922.